Enhanced Expression of Transgenes from Adeno-Associated Virus Vectors with the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element: Implications for Gene Therapy
- 20 September 1999
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 10 (14), 2295-2305
- https://doi.org/10.1089/10430349950016942
Abstract
The woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) evolved to stimulate the expression of intronless viral messages. To determine whether this ability to enhance expression could be useful in nonviral and heterologous viral gene delivery systems, we analyzed the ability of the WPRE to elevate the expression of a cDNA encoding the green fluorescent protein (GFP) in these contexts. We find that the WPRE can stimulate the expression of GFP when the gene is delivered by transfection or transduction with recombinant adeno-associated virus (AAV). Enhancement occurred both during transient expression and when the gene is stably incorporated into the genome of target cells. This enhancement required that the WPRE be located in cis within the GFP message, and was observed in both transformed cell lines and primary human fibroblasts. These results demonstrate that the WPRE will be an effective tool for increasing the long-term expression of transgenes in gene therapy.Keywords
This publication has 47 references indexed in Scilit:
- THE GREEN FLUORESCENT PROTEINAnnual Review of Biochemistry, 1998
- Efficient 3'-end formation of human beta-globin mRNA in vivo requires sequences within the last intron but occurs independently of the splicing reactionNucleic Acids Research, 1998
- Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsNature Genetics, 1997
- Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous SystemExperimental Neurology, 1997
- Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1996
- Construction of Human Factor IX Expression Vectors in Retroviral Vector Frames Optimized for Muscle CellsHuman Gene Therapy, 1996
- Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene TherapyHuman Gene Therapy, 1994
- Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.Proceedings of the National Academy of Sciences, 1993
- Adeno-associated virus vectorsCurrent Opinion in Biotechnology, 1992
- The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNANature, 1989